Arizona Experience
05/17/2013Cyanobacteria for Solar Powered Biofuels
ASU scientists are developing a new, renewable source of biodiesel and other green products. Our scientists are developing genetically optimized versions of photosynthetic bacteria, called cyanobacteria, that will use sunlight, water and carbon dioxide to over-produce and secrete fatty acids as a raw material for the production of biofuel. This revolutionary concept shifts the focus from growing dense cultures of algae or bacteria for harvest of fats to a continuous microbial production system as biocatalysts (mini factories) from which a renewable fuel feedstock, namely fatty acids, is collected and converted into biofuel.
Arizona Experience
05/17/2013TGen and the Human Genome Project
Dr. Jeffrey Trent, President and Research Director of TGen, speaks on how the use of genetic information to personalize treatment can lead to whole new way of fighting disease. Read the article Genomic Research
Arizona Experience
05/17/2013Algal Biofuels Consortium
The primary objective is to evaluate biochemical (enzymatic) conversion as a potentially viable strategy for converting algal biomass into lipid-based and carbohydrate-based biofuels. Secondary objective is to test the acceptability of algal biofuels as replacements for petroleum-based fuels.The program supports the development of a clean, sustainable transportation sector – a goal of the Department of Energy's (DOE) continued effort to spur the creation of a domestic bio-industry while creating jobs. This round of DOE funding totals $24 million for three research groups to tackle key hurdles in the commercialization of algae-based biofuels.The Arizona State University-led group, the Sustainable Algal Biofuels Consortium, will focus on testing the acceptability of algal biofuels as replacements for petroleum-derived fuels. The group will investigate biochemical conversion of algae to fuels and products, and analyze the physical chemistry properties of algal fuels and fuel intermediates. In addition to Arizona State University, other core members of the consortium are the National Renewable Energy Laboratory, Golden, Colo., and Sandia National Laboratories, Albuquerque.
AZBio Members
06/22/2013Company Presentation: Invoy Technologies, LLC
AZBio Members
05/17/2013Partnering in the New Age of R&D
There is a major shift occurring in our industries with companies
large and small. None of us are looking
to go it alone in a world where new product development can range from millions
to BILLIONS.
Again we looked to experts from the front lines for insights...
Panelists: Paul
August, VP and head of the early to candidate program for Sanofi, US ; Babak
Nemat of founder of Strategic
Intelligence and advisor to J&J, Bill Mulholland of Snell & Wilmer, Joan Koerber-Walker, AZBio (moderator)
AZBio Members
05/17/2013Bio Ag: Foresight and Integrating Vision Systems
The University of Arizona Controlled Environment Agriculture CenterControlled Environment Agriculture (CEA) is the production of plants and their products, such as vegetables and flowers, inside structures such as greenhouses. By using CEA, we can produce high value crops at maximum productivity in an efficient and environmentally friendly way.
The University of Arizona's Controlled Environment Agriculture Center (CEAC) supports education, research and outreach as part of the Department of Agricultural & Biosystems Engineering and the School of Plant Sciences - both programs of the College of Agriculture and Life Sciences. CEAC also offers an innovation platform for plant physiology, sensor technology and applied computer technology.
AZBio Members
06/15/2013Company Presentation: Solvonics Medical
Frank Pipitone of Solvonics Medical demonstrates the value of the BloodHound(TM) at AZBio Expo 2013
AZBio Members
10/19/2013Ventana: The Birth of a Life Changing Idea
Ventana Medical Systems, Inc., a Member of the Roche Group, is a global leader in tissue diagnostic innovations for anatomic pathology. This video reveals the true story of a quest to improve the standard of care for a single patient -- a quest that began a new era in cancer diagnostics. Discover how automated staining is empowering histology labs worldwide to deliver prompt, personalized diagnostic information.
AZBio Members
05/17/2013Tying it all together for start up success
Alan Nelson is heading the Predictive Health Analytics Initiative that aims to change the paradigm in healthcare from treating late stage disease to early diagnosis and preventive therapies that are cost-effective. He served as the Executive Director of the Biodesign Institute at ASU and holds professorships in Bioengineering and physics. He is the founder and CEO of three companies, the most recent being VisionGate, the innovator of the LuCED lung cancer early detection test. VisionGate was awarded the start-up of the year award at the recent Governors’ celebration of innovation. Alan has a PhD in Biophysics from Berkeley, holds 66 issued patents, and has published over 100 scholarly papers in biomedical imaging.
